251 related articles for article (PubMed ID: 36864951)
1. Atherosclerotic plaque composition and specific endovascular considerations in the end stage renal disease patients: a narrative review.
Ruff C; Artzner C; Nikoalou K; Grözinger G
Cardiovasc Diagn Ther; 2023 Feb; 13(1):133-146. PubMed ID: 36864951
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease.
Anantha-Narayanan M; Sheikh AB; Nagpal S; Jelani QU; Smolderen KG; Regan C; Ionescu C; Ochoa Chaar CI; Schneider M; Llanos-Chea F; Mena-Hurtado C
J Vasc Surg; 2021 Jan; 73(1):331-340.e4. PubMed ID: 32889074
[TBL] [Abstract][Full Text] [Related]
3. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and impact of carbon dioxide angiography on acute kidney injury following endovascular interventions in patients with peripheral artery disease and renal impairment.
Jakobi T; Meyborg M; Freisinger E; Gebauer K; Stella J; Engelbertz C; Reinecke H; Malyar NM
J Nephrol; 2021 Jun; 34(3):811-820. PubMed ID: 33555574
[TBL] [Abstract][Full Text] [Related]
5. Implications of Kidney Disease in Patients with Peripheral Arterial Disease and Vascular Calcification.
Mantha Y; Asif A; Fath A; Prasad A
Interv Cardiol Clin; 2023 Oct; 12(4):531-538. PubMed ID: 37673497
[TBL] [Abstract][Full Text] [Related]
6. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.
Fujihara M; Kawasaki D; Shintani Y; Fukunaga M; Nakama T; Koshida R; Higashimori A; Yokoi Y;
Catheter Cardiovasc Interv; 2015 Apr; 85(5):870-7. PubMed ID: 25380326
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
9. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease.
Smilowitz NR; Bhandari N; Berger JS
Atherosclerosis; 2020 Mar; 297():149-156. PubMed ID: 31948675
[TBL] [Abstract][Full Text] [Related]
10. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Hybrid Angiography in Chronic Lower Extremity Ischemia Patients at Risk of Contrast-Induced Acute Kidney Injury.
Taha AG; Saleh M; Ali H
Vasc Endovascular Surg; 2022 Feb; 56(2):180-189. PubMed ID: 34783267
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of endovascular therapy by diluted contrast digital subtraction angiography in patients with chronic kidney disease.
Hayakawa N; Kodera S; Ohki N; Kanda J
Heart Vessels; 2019 Nov; 34(11):1740-1747. PubMed ID: 30989328
[TBL] [Abstract][Full Text] [Related]
14. Unique aspects of peripheral artery disease in patients with chronic kidney disease.
Arinze NV; Gregory A; Francis JM; Farber A; Chitalia VC
Vasc Med; 2019 Jun; 24(3):251-260. PubMed ID: 30823859
[TBL] [Abstract][Full Text] [Related]
15. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease.
Adedokun SD; Sarwar M; Hwang K; Hans A; Baskaran J; Anantha Narayanan M
J Cardiovasc Surg (Torino); 2023 Dec; 64(6):624-633. PubMed ID: 38078709
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Mortality After Invasive Angiography and Endovascular Revascularization in Patients With PAD Having Chronic Kidney Disease.
Gebauer K; Engelbertz C; Malyar NM; Meyborg M; Lüders F; Freisinger E; Reinecke H
Angiology; 2016 Jul; 67(6):556-64. PubMed ID: 26324203
[TBL] [Abstract][Full Text] [Related]
18. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes.
Baber U; Stone GW; Weisz G; Moreno P; Dangas G; Maehara A; Mintz GS; Cristea E; Fahy M; Xu K; Lansky AJ; Wennerblom B; Mathey DG; Templin B; Zhang Z; Serruys PW; Mehran R
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S53-61. PubMed ID: 22421231
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
